Price (delayed)
$329.99
Market cap
$84.99B
P/E Ratio
25.96
Dividend/share
N/A
EPS
$12.71
Enterprise value
$76.49B
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather
There are no recent dividends present for VRTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.